Validity of self-reported weight: a study of urban brazilian adults

Para avaliar a validade do peso auto-referido em inquéritos de prevalência de obesidade, o mesmo foi comparado com o peso medido de 659 adultos, residentes em Porto Alegre, RS, Brasil, em 1986-87. Ambos os pesos foram obtidos por entrevistador, na casa do participante, na mesma ocasião. A média das diferenças entre peso auto-referido e peso medido foi pequena (-0,06 +/-3,16 kg; média +/- desvio padrão) e a correlação entre eles alta (r=0,97). Sessenta e dois por cento dos participantes referiram seu peso com erro < 2 kg, 87% com erro menor do que 4 kg e 95% com erro < 6 kg. Indivíduos de baixo peso hiperestimaram seu peso, o oposto ocorrendo com indivíduos obesos (p; 30) por peso referido, foi de 10% e a por peso medido, de 11%. Concluindo, a validade do peso auto-referido é aceitável para inquéritos de prevalência realizados em contextos similares.In order to evaluate the validity of self-reported weight for use in obesity prevalence surveys, self-reported weight was compared to measured weight for 659 adults living in the Porto Alegre county, RS Brazil in 1986-87, both weights being obtained by a technician in the individual's home on the same visit. The mean difference between self-reported and measured weight was small (-0.06 +/- 3.16 kg; mean +/- standard deviation), and the correlation between reported and measured weight was high (r=0.97). Sixty-two percent of participants reported their weight with an error of < 2 kg, 87% with an error of < 4 kg, and 95% with an error of < 6 kg. Underweight individuals overestimated their weight, while obese individuals underestimated theirs (p; 30) by reported weight was 10%, by measured weight 11%. Thus, the validity of reported weight is acceptable for surveys of the prevalence of ponderosity in similar settings

Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART

This study evaluated the impact of 9 single nucleotide polymorphisms (SNPs) in 6 candidate genes (APOB, APOA5, APOE, APOC3, SCAP, and LDLR) over dyslipidemia in HIV-infected patients on stable antiretroviral therapy (ART) with undetectable viral loads. Blood samples were collected from 614 patients at reference services in the cities of Porto Alegre, Pelotas, and Rio Grande in Brazil. The SNPs were genotyped by conventional polymerase chain reaction (PCR) and real-time PCR. The prevalence of dyslipidemia was particularly high among the protease inhibitors-treated patients (79%). APOE (rs429358 and rs7412) genotypes and APOA5 −1131T>C (rs662799) were associated with plasma triglycerides (TG) and low-density-lipoprotein cholesterol levels (LDL-C). The APOA5 −1131T>C (rs662799) and SCAP 2386A>G (rs12487736) polymorphisms were significantly associated with high-density-lipoprotein cholesterol levels. The mean values of the total cholesterol and LDL-C levels were associated with both the APOB SP Ins/Del (rs17240441) and APOB XbaI (rs693) polymorphisms. In conclusion, our data support the importance of genetic factors in the determination of lipid levels in HIV-infected individuals. Due to the relatively high number of carriers of these risk variants, studies to verify treatment implications of genotyping before HAART initiation may be advisable to guide the selection of an appropriate antiretroviral therapy regimen

Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: A follow up study

<p>Abstract</p> <p>Background</p> <p>In 2001 Brazilian citizens aged 40 or older were invited to participate in a nationwide population screening program for diabetes. Capillary glucose screening tests and procedures for diagnostic confirmation were offered through the national healthcare system, diagnostic priority being given according to the severity of screening results. The objective of this study is to evaluate the initial impact of the program.</p> <p>Methods</p> <p>Positive testing was defined by a fasting capillary glucose ≥ 100 mg/dL or casual glucose ≥ 140 mg/dL. All test results were tabulated locally and aggregate data by gender and clinical categories were sent to the Ministry of Health. To analyze individual characteristics of screening tests performed, a stratified random sample of 90,106 tests was drawn. To describe the actions taken for positive screenees, a random sub-sample of 4,906 positive screenees was actively followed up through home interviews.</p> <p>Main outcome measures considered were the number of diabetes cases diagnosed and cost per case detected and incorporated into healthcare.</p> <p>Results</p> <p>Of 22,069,905 screening tests performed, we estimate that 3,417,106 (95% CI 3.1 – 3.7 million) were positive and that 346,168 (290,454 – 401,852) new cases were diagnosed (10.1% of positives), 319,157 (92.2%) of these being incorporated into healthcare. The number of screening tests needed to detect one case of diabetes was 64. As many cases of untreated but previously known diabetes were also linked to healthcare providers during the Campaign, the estimated number needed screen to incorporate one case into the healthcare system was 58. Total screening and diagnostic costs were US$26.19 million, the cost per diabetes case diagnosed being US$ 76. Results were especially sensitive to proportion of individuals returning for diagnostic confirmation.</p> <p>Conclusion</p> <p>This nationwide population-based screening program, conducted through primary healthcare services, demonstrates the feasibility, within the context of an organized national healthcare system, of screening campaigns for chronic diseases. Although overall costs were significant, cost per new case diagnosed was lower than previously reported. However, cost-effectiveness analysis based on more clinically significant outcomes needs to be conducted before this screening approach can be recommended in other settings.</p

Fatores de risco para doenças não-transmissíveis em área metropolitana na região sul do Brasil: prevalência e simultaneidade

Três quartos da mortalidade no Estado do Rio Grande do Sul (Brasil) ocorrem por doenças não-transmissíveis. Dentre elas as doenças cardiovasculares, por si só, correspondem a 35% das causas de morte. Para avaliar a prevalência de fatores de risco para essas doenças, foi realizado inquérito domiciliar no período de 1986/87. Foram entrevistados 1.157 indivíduos entre 15-64 anos, residentes em setores censitários de 4 áreas docente-assistenciais do Município de Porto Alegre, RS. A prevalência padronizada de tabagismo foi de 40%, hipertensão 14%, obesidade 18%, sedentarismo geral 47% e consumo excessivo de álcool, 7%. Trinta e nove por cento da amostra acumulavam dois ou mais desses cinco fatores de risco, somente 22% de homens e 21% de mulheres não apresentaram esses fatores de risco. As elevadas freqüências e concomitâncias desses fatores de risco alertam para sua importância em programas que visam a prevenção das doenças não-transmissíveis